Abstract
Gastrointestinal (GI) dysfunction is a common comorbidity of autism spectrum disorders (ASD) and is associated with increased severity of characteristic autism-associated symptoms. However, the underlying biological mechanisms for GI dysfunction symptoms in children with ASD are unknown. This review explores potential explanations for these symptoms including altered enteric microbiota, impaired intestinal permeability, changes in immune homeostasis, and genetic factors such as single nucleotide polymorphisms. It was shown that genetic factors not only influence the development of altered enteric microbiota and impaired intestinal permeability, but also are a strong, independent contributor to GI dysfunction in ASD patients.
Similar content being viewed by others
References
Adams, J. B., Johansen, L. J., Powell, L. D., Quig, D., & Rubin, R. A. (2011). Gastrointestinal flora and gastrointestinal status in children with autism--comparisons to typical children and correlation with autism severity. BMC Gastroenterology, 11(1), 22.
Ahmad, R., Sorrell, M., Batra, S., Dhawan, P., & Singh, A. (2017). Gut permeability and mucosal inflammation: bad, good or context dependent. Mucosal Immunology, 10(2), 307.
Alabbas, S. Y., Begun, J., Florin, T. H., & Oancea, I. (2018). The role of IL-22 in the resolution of sterile and nonsterile inflammation. Clinical & translational immunology, 7(4), e1017.
Al-Sadi, R., Ye, D., Boivin, M., Guo, S., Hashimi, M., Ereifej, L., & Ma, T. Y. (2014). Interleukin-6 modulation of intestinal epithelial tight junction permeability is mediated by JNK pathway activation of claudin-2 gene. PLoS One, 9(3), e85345.
Al-Sadi, R., Guo, S., Ye, D., Rawat, M., & Ma, T. Y. (2016). TNF-α modulation of intestinal tight junction permeability is mediated by NIK/IKK-α axis activation of the canonical NF-κB pathway. The American Journal of Pathology, 186(5), 1151–1165.
Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., Liu, H., Cross, J. R., Pfeffer, K., Coffer, P. J., & Rudensky, A. Y. (2013). Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature, 504(7480), 451.
Arrieta, M.-C., Madsen, K., Doyle, J., & Meddings, J. B. (2008). Reducing small intestinal permeability attenuates colitis in the IL-10 gene deficient mouse. Gut.
Ashwood, P., & Wakefield, A. J. (2006). Immune activation of peripheral blood and mucosal CD3+ lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms. Journal of Neuroimmunology, 173(1–2), 126–134.
Australian Institute of Health and Welfare. (2017). Autism in Australia. Retrieved from https://www.aihw.gov.au/reports/disability/autism-in-australia/contents/autism. Accessed 1 December 2017
Autism Ontario. (2017). Thinking about autism spectrum disorder, on Autism Ontario. Retrieved from https://www.autismontario.com/client/aso/ao.nsf/web/Info+about+ASD?OpenDocument Accessed 1 December 2017
Bachmann, C. J., Gerste, B., & Hoffmann, F. (2016). Diagnoses of autism spectrum disorders in Germany: time trends in administrative prevalence and diagnostic stability. Autism, 1362361316673977.
Bennet, S. M., Böhn, L., Störsrud, S., Liljebo, T., Collin, L., Lindfors, P., Törnblom, H., Öhman, L., & Simrén, M. (2018). Multivariate modelling of faecal bacterial profiles of patients with IBS predicts responsiveness to a diet low in FODMAPs. Gut, 67(5), 872–881.
Benson, A. K., Kelly, S. A., Legge, R., Ma, F., Low, S. J., Kim, J., Zhang, M., Oh, P. L., Nehrenberg, D., & Hua, K. (2010). Individuality in gut microbiota composition is a complex polygenic trait shaped by multiple environmental and host genetic factors. Proceedings of the National Academy of Sciences, 107(44), 18933–18938.
Bischoff, S. C., Barbara, G., Buurman, W., Ockhuizen, T., Schulzke, J.-D., Serino, M., Tilg, H., Watson, A., & Wells, J. M. (2014). Intestinal permeability–a new target for disease prevention and therapy. BMC Gastroenterology, 14(1), 189.
Black, C., Kaye, J. A., & Jick, H. (2002). Relation of childhood gastrointestinal disorders to autism: nested case-control study using data from the UK General Practice Research Database. BMJ, 325(7361), 419–421.
Bourgeron, T. (2015). From the genetic architecture to synaptic plasticity in autism spectrum disorder. Nature Reviews Neuroscience, 16(9), 551.
Buie, T., Campbell, D. B., Fuchs, G. J., Furuta, G. T., Levy, J., VandeWater, J., Whitaker, A. H., Atkins, D., Bauman, M. L., & Beaudet, A. L. (2010). Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report. Pediatrics, 125(Supplement 1), S1–S18.
Capaldo, C. T., & Nusrat, A. (2009). Cytokine regulation of tight junctions. Biochimica et Biophysica Acta (BBA)-Biomembranes, 1788(4), 864–871.
Careaga, M., Rogers, S., Hansen, R. L., Amaral, D. G., Van de Water, J., & Ashwood, P. (2017). Immune endophenotypes in children with autism spectrum disorder. Biological Psychiatry, 81(5), 434–441.
Careaga, M., Taylor, S. L., Chang, C., Chiang, A., Ku, K. M., Berman, R. F., Van de Water, J. A., & Bauman, M. D. (2018). Variability in PolyIC induced immune response: implications for preclinical maternal immune activation models. Journal of Neuroimmunology, 323, 87–93.
Cayrol, C., & Girard, J.-P. (2014). IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy. Current Opinion in Immunology, 31, 31–37.
Center for Disease Control and Prevention. (2016). Autism spectrum disorder (ASD) data and statistics. Retrieved from https://www.cdc.gov/ncbddd/autism/data.html
Cepek, K. L., Shaw, S. K., Parker, C. M., Russell, G. J., Morrow, J. S., Rimm, D. L., & Brenner, M. B. (1994). Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the αEβ7 integrin. Nature, 372(6502), 190.
Claesson, M. J., Clooney, A. G., & O’toole, P. W. (2017). A clinician’s guide to microbiome analysis. Nature Reviews Gastroenterology and Hepatology, 14(10), 585.
Clarke, G., Quigley, E. M., Cryan, J. F., & Dinan, T. G. (2009). Irritable bowel syndrome: towards biomarker identification. Trends in Molecular Medicine, 15(10), 478–489.
Clarke, G., Grenham, S., Scully, P., Fitzgerald, P., Moloney, R., Shanahan, F., Dinan, T. G., & Cryan, J. (2013). The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Molecular Psychiatry, 18(6), 666.
Croen, L. A., Najjar, D. V., Ray, G. T., Lotspeich, L., & Bernal, P. (2006). A comparison of health care utilization and costs of children with and without autism spectrum disorders in a large group-model health plan. Pediatrics, 118(4), e1203–e1211.
Cummings, C. M., Caporino, N. E., & Kendall, P. C. (2014). Comorbidity of anxiety and depression in children and adolescents: 20 years after. Psychological Bulletin, 140(3), 816.
Cunningham, K. E., & Turner, J. R. (2012). Myosin light chain kinase: pulling the strings of epithelial tight junction function. Annals of the New York Academy of Sciences, 1258(1), 34–42.
Daraei, A., Salehi, R., & Mohamadhashem, F. (2012). PTGS2 (COX2)− 765G> C gene polymorphism and risk of sporadic colorectal cancer in Iranian population. Molecular Biology Reports, 39(5), 5219–5224.
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., & Fischbach, M. A. (2014). Diet rapidly and reproducibly alters the human gut microbiome. Nature, 505(7484), 559–563.
de Magistris, L., Familiari, V., Pascotto, A., Sapone, A., Frolli, A., Iardino, P., Carteni, M., De Rosa, M., Francavilla, R., & Riegler, G. (2010). Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives. Journal of Pediatric Gastroenterology and Nutrition, 51(4), 418–424.
Devkota, S., Wang, Y., Musch, M. W., Leone, V., Fehlner-Peach, H., Nadimpalli, A., Antonopoulos, D. A., Jabri, B., & Chang, E. B. (2012). Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10−/−mice. Nature, 487(7405), 104–108.
Dinan, T. G., & Cryan, J. F. (2017). The microbiome-gut-brain axis in health and disease. Gastroenterology Clinics, 46(1), 77–89.
Dissanayake, C., Bui, Q., Bulhak-Paterson, D., Huggins, R., & Loesch, D. Z. (2009). Behavioural and cognitive phenotypes in idiopathic autism versus autism associated with fragile X syndrome. Journal of Child Psychology and Psychiatry, 50(3), 290–299.
Donaldson, G. P., Lee, S. M., & Mazmanian, S. K. (2016). Gut biogeography of the bacterial microbiota. Nature Reviews Microbiology, 14(1), 20–32.
Edelson, S. M. (2016). Autism Treatment Evaluation Chekclist (ATEC). Retrieved from https://www.autism.com/ind_atec Accessed 1 September 2018.
Elsabbagh, M., Divan, G., Koh, Y. J., Kim, Y. S., Kauchali, S., Marcín, C., Montiel-Nava, C., Patel, V., Paula, C. S., & Wang, C. (2012). Global prevalence of autism and other pervasive developmental disorders. Autism Research, 5(3), 160–179.
Esnafoglu, E., Cırrık, S., Ayyıldız, S. N., Erdil, A., Ertürk, E. Y., Daglı, A., & Noyan, T. (2017). Increased serum zonulin levels as an intestinal permeability marker in autistic subjects. The Journal of Pediatrics, 188, 240–244.
Falcón, B. S., López, M. B., Muñoz, B. M., Sánchez, A. Á., & Rey, E. (2016). Fecal impaction: a systematic review of its medical complications. BMC Geriatrics, 16(1), 4.
Fasano, A. (2012). Zonulin, regulation of tight junctions, and autoimmune diseases. Annals of the New York Academy of Sciences, 1258(1), 25–33.
Finegold, S. M., Molitoris, D., Song, Y., Liu, C., Vaisanen, M.-L., Bolte, E., McTeague, M., Sandler, R., Wexler, H., & Marlowe, E. M. (2002). Gastrointestinal microflora studies in late-onset autism. Clinical Infectious Diseases, 35(Supplement_1), S6–S16.
Finegold, S. M., Summanen, P. H., Downes, J., Corbett, K., & Komoriya, T. (2017). Detection of Clostridium perfringens toxin genes in the gut microbiota of autistic children. Anaerobe.
Fishman, D., Faulds, G., Jeffery, R., Mohamed-Ali, V., Yudkin, J. S., Humphries, S., & Woo, P. (1998). The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. Journal of Clinical Investigation, 102(7), 1369.
Flemer, B., Lynch, D. B., Brown, J. M., Jeffery, I. B., Ryan, F. J., Claesson, M. J., O’riordain, M., Shanahan, F., & O’toole, P. W. (2017). Tumour-associated and non-tumour-associated microbiota in colorectal cancer. Gut, 66(4), 633–643.
Flint, H. J., Bayer, E. A., Rincon, M. T., Lamed, R., & White, B. A. (2008). Polysaccharide utilization by gut bacteria: potential for new insights from genomic analysis. Nature Reviews Microbiology, 6(2), 121.
Fulceri, F., Morelli, M., Santocchi, E., Cena, H., Del Bianco, T., Narzisi, A., Calderoni, S., & Muratori, F. (2016). Gastrointestinal symptoms and behavioral problems in preschoolers with autism spectrum disorder. Digestive and Liver Disease, 48(3), 248–254.
Gershon, M. (2004). Serotonin receptors and transporters—roles in normal and abnormal gastrointestinal motility. Alimentary Pharmacology & Therapeutics, 20(s7), 3–14.
Gershon, M. D. (2013). 5-Hydroxytryptamine (serotonin) in the gastrointestinal tract. Current Opinion in Endocrinology, Diabetes, and Obesity, 20(1), 14.
Gorfu, G., Rivera-Nieves, J., & Ley, K. (2009). Role of β7 integrins in intestinal lymphocyte homing and retention. Current Molecular Medicine, 9(7), 836–850.
Gorrindo, P., Williams, K. C., Lee, E. B., Walker, L. S., McGrew, S. G., & Levitt, P. (2012). Gastrointestinal dysfunction in autism: parental report, clinical evaluation, and associated factors. Autism Research, 5(2), 101–108.
Gröne, J., Weber, B., Staub, E., Heinze, M., Klaman, I., Pilarsky, C., Hermann, K., Castanos-Velez, E., Röpcke, S., & Mann, B. (2007). Differential expression of genes encoding tight junction proteins in colorectal cancer: frequent dysregulation of claudin-1,-8 and-12. International Journal of Colorectal Disease, 22(6), 651–659.
Hugenholtz, F., & de Vos, W. M. (2018). Mouse models for human intestinal microbiota research: a critical evaluation. Cellular and Molecular Life Sciences, 75(1), 149–160.
Irish Society for Autism. (2017). What is autism (autism spectrum disorders)? Retrieved from https://autism.ie/what-is-autism/ Accessed 1 December 2017.
Jeste, D., Lieberman, J. A., Fassler, D., & Peele, R. (2013). Diagnostic and statistical manuel of mental disorders DSM-5 (5th ed.). Washington, DC: American Psychiatric Publishing.
Johnson, C. R., Handen, B. L., Zimmer, M., Sacco, K., & Turner, K. (2011). Effects of gluten free/casein free diet in young children with autism: a pilot study. Journal of Developmental and Physical Disabilities, 23(3), 213–225.
Kang, V., Wagner, G. C., & Ming, X. (2014). Gastrointestinal dysfunction in children with autism spectrum disorders. Autism Research, 7(4), 501–506.
Kawamura, Y., Takahashi, O., & Ishii, T. (2008). Reevaluating the incidence of pervasive developmental disorders: impact of elevated rates of detection through implementation of an integrated system of screening in Toyota, Japan. Psychiatry and Clinical Neurosciences, 62(2), 152–159.
Keszthelyi, D., Troost, F., Jonkers, D., Eijk, H., Lindsey, P., Dekker, J., Buurman, W. A., & Masclee, A. (2014). Serotonergic reinforcement of intestinal barrier function is impaired in irritable bowel syndrome. Alimentary Pharmacology & Therapeutics, 40(4), 392–402.
Krakowiak, P., Goines, P. E., Tancredi, D. J., Ashwood, P., Hansen, R. L., Hertz-Picciotto, I., & Van de Water, J. (2017). Neonatal cytokine profiles associated with autism spectrum disorder. Biological Psychiatry, 81(5), 442–451.
Kushak, R. I., Buie, T. M., Murray, K. F., Newburg, D. S., Chen, C., Nestoridi, E., & Winter, H. S. (2016). Evaluation of intestinal function in children with autism and gastrointestinal symptoms. Journal of Pediatric Gastroenterology and Nutrition, 62(5), 687–691.
Landi, S., Moreno, V., Gioia-Patricola, L., Guino, E., Navarro, M., de Oca, J., Capella, G., & Canzian, F. (2003). Association of common polymorphisms in inflammatory genes interleukin (IL) 6, IL8, tumor necrosis factor α, NFKB1, and peroxisome proliferator-activated receptor γ with colorectal cancer. Cancer Research, 63(13), 3560–3566.
Lázaro, C. P., Pondé, M. P., & Rodrigues, L. E. (2016). Opioid peptides and gastrointestinal symptoms in autism spectrum disorders. Revista Brasileira de Psiquiatria, 38(3), 243–246.
Lee, S. H. (2015). Intestinal permeability regulation by tight junction: implication on inflammatory bowel diseases. Intestinal Research, 13(1), 11–18.
Li, E., Hamm, C. M., Gulati, A. S., Sartor, R. B., Chen, H., Wu, X., Zhang, T., Rohlf, F. J., Zhu, W., & Gu, C. (2012). Inflammatory bowel diseases phenotype, C. difficile and NOD2 genotype are associated with shifts in human ileum associated microbial composition. PLoS One, 7(6), e26284.
Li, L., Xiong, L., Yao, J., Zhuang, X., Zhang, S., Yu, Q., Xiao, Y., Cui, Y., & Chen, M. (2016). Increased small intestinal permeability and RNA expression profiles of mucosa from terminal ileum in patients with diarrhoea-predominant irritable bowel syndrome. Digestive and Liver Disease, 48(8), 880–887.
Liu, F., Wei, W.-Q., Cormier, R. T., Zhang, S.-T., Qiao, Y.-L., Li, X.-Q., Zhu, S.-T., Zhai, Y.-C., Peng, X.-X., & Yan, Y.-X. (2013). Association of single nucleotide polymorphisms in the prostaglandin-endoperoxide synthase 2 (PTGS2) and phospholipase A2 group IIA (PLA2G2A) genes with susceptibility to esophageal squamous cell carcinoma. Asian Pacific Journal of Cancer Prevention: APJCP, 15(4), 1797–1802.
Liu, S., da Cunha, A. P., Rezende, R. M., Cialic, R., Wei, Z., Bry, L., Comstock, L. E., Gandhi, R., & Weiner, H. L. (2016). The host shapes the gut microbiota via fecal microRNA. Cell Host & Microbe, 19(1), 32–43.
Luna, R. A., Oezguen, N., Balderas, M., Venkatachalam, A., Runge, J. K., Versalovic, J., Veenstra-VanderWeele, J., Anderson, G. M., Savidge, T., & Williams, K. C. (2017). Distinct microbiome-neuroimmune signatures correlate with functional abdominal pain in children with autism spectrum disorder. Cellular and Molecular Gastroenterology and Hepatology, 3(2), 218–230.
MacFabe, D. F. (2012). Short-chain fatty acid fermentation products of the gut microbiome: implications in autism spectrum disorders. Microbial Ecology in Health and Disease, 23(1), 19260.
Malinen, E., Rinttilä, T., Kajander, K., Mättö, J., Kassinen, A., Krogius, L., Saarela, M., Korpela, R., & Palva, A. (2005). Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. The American Journal of Gastroenterology, 100(2), 373.
Margolis, K. G., & Gershon, M. D. (2016). Enteric neuronal regulation of intestinal inflammation. Trends in Neurosciences, 39(9), 614–624.
Margolis, K. G., Li, Z., Stevanovic, K., Saurman, V., Israelyan, N., Anderson, G. M., Snyder, I., Veenstra-VanderWeele, J., Blakely, R. D., & Gershon, M. D. (2016). Serotonin transporter variant drives preventable gastrointestinal abnormalities in development and function. The Journal of Clinical Investigation, 126(6), 2221–2235.
Martìn-Padura, I., Lostaglio, S., Schneemann, M., Williams, L., Romano, M., Fruscella, P., Panzeri, C., Stoppacciaro, A., Ruco, L., & Villa, A. (1998). Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. The Journal of Cell Biology, 142(1), 117–127.
Mayer, E. A., & Tillisch, K. (2011). The brain-gut axis in abdominal pain syndromes. Annual review of medicine, 62, 381–396.
McElhanon, B. O., McCracken, C., Karpen, S., & Sharp, W. G. (2014). Gastrointestinal symptoms in autism spectrum disorder: a meta-analysis. Pediatrics, 133(5), 872–883.
Menke, V., Pot, R. G., Moons, L. M., van Zoest, K. P., Hansen, B., van Dekken, H., Siersema, P. D., Kusters, J. G., & Kuipers, E. J. (2012). Functional single-nucleotide polymorphism of epidermal growth factor is associated with the development of Barrett’s esophagus and esophageal adenocarcinoma. Journal of Human Genetics, 57(1), 26–32.
Ming, X., Brimacombe, M., Chaaban, J., Zimmerman-Bier, B., & Wagner, G. C. (2008). Autism spectrum disorders: concurrent clinical disorders. Journal of Child Neurology, 23(1), 6–13.
Mujagic, Z., Ludidi, S., Keszthelyi, D., Hesselink, M., Kruimel, J., Lenaerts, K., Hanssen, N. M. J., Conchillo, J. M., Jonkers, D. M. A. E., & Masclee, A. (2014). Small intestinal permeability is increased in diarrhoea predominant IBS, while alterations in gastroduodenal permeability in all IBS subtypes are largely attributable to confounders. Alimentary Pharmacology & Therapeutics, 40(3), 288–297.
Muniz, L. R., Knosp, C., & Yeretssian, G. (2012). Intestinal antimicrobial peptides during homeostasis, infection, and disease. Frontiers in Immunology, 3, 310.
Nezami, B. G., & Srinivasan, S. (2010). Enteric nervous system in the small intestine: pathophysiology and clinical implications. Current Gastroenterology Reports, 12(5), 358–365.
NHS Digital UK (2012). Estimating the prevalence of autism spectrum conditions in adults - extending the 2007 adult psychiatric morbidity survey. Retrieved from https://digital.nhs.uk/data-and-information/publications/statistical/estimating-the-prevalence-of-autism-spectrum-conditions-in-adults/estimating-the-prevalence-of-autism-spectrum-conditions-in-adults-extending-the-2007-adult-psychiatric-morbidity-survey Accessed 1 December 2017.
Nikolov, R. N., Bearss, K. E., Lettinga, J., Erickson, C., Rodowski, M., Aman, M. G., McCracken, J. T., McDougle, C. J., Tierney, E., & Vitiello, B. (2009). Gastrointestinal symptoms in a sample of children with pervasive developmental disorders. Journal of Autism and Developmental Disorders, 39(3), 405–413.
O’Mahony, S., Clarke, G., Borre, Y., Dinan, T., & Cryan, J. (2015). Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behavioural Brain Research, 277, 32–48.
Panksepp, J. (1979). A neurochemical theory of autism. Trends in Neurosciences, 2, 174–177.
Park, Y., Won, S., Nam, M., Chung, J.-H., & Kwack, K. (2014). Interaction between MAOA and FOXP2 in association with autism and verbal communication in a Korean population. Journal of Child Neurology, 29(12), NP207–NP211.
Parracho, H. M., Bingham, M. O., Gibson, G. R., & McCartney, A. L. (2005). Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. Journal of Medical Microbiology, 54(10), 987–991.
Peters, B., Williams, K. C., Gorrindo, P., Rosenberg, D., Lee, E. B., Levitt, P., & Veenstra-VanderWeele, J. (2014). Rigid–compulsive behaviors are associated with mixed bowel symptoms in autism spectrum disorder. Journal of Autism and Developmental Disorders, 44(6), 1425–1432.
Piche, T., Barbara, G., Aubert, P., Des Varannes, S. B., Dainese, R., Nano, J.-L., Cremon, C., Stanghellini, V., De Giorgio, R., & Galmiche, J. P. (2009). Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. Gut, 58(2), 196–201.
Porter, N. T., & Martens, E. C. (2017). The critical roles of polysaccharides in gut microbial ecology and physiology. Annual Review of Microbiology, 71, 349–369.
Quintana, F. J., Basso, A. S., Iglesias, A. H., Korn, T., Farez, M. F., Bettelli, E., Caccamo, M., Oukka, M., & Weiner, H. L. (2008). Control of T reg and T H 17 cell differentiation by the aryl hydrocarbon receptor. Nature, 453(7191), 65.
Rose, D. R., Yang, H., Serena, G., Sturgeon, C., Ma, B., Careaga, M., Hughes, H. K., Angkustsiri, K., Rose, M., & Hertz-Picciotto, I. (2018). Differential immune responses and microbiota profiles in children with autism spectrum disorders and co-morbid gastrointestinal symptoms. Brain, Behavior, and Immunity, 70, 354–368.
Saulnier, D. M., Riehle, K., Mistretta, T. A., Diaz, M. A., Mandal, D., Raza, S., Weidler, E. M., Qin, X., Coarfa, C., & Milosavljevic, A. (2011). Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology, 141(5), 1782–1791.
Schmidt, R. J., Hansen, R. L., Hartiala, J., Allayee, H., Schmidt, L. C., Tancredi, D. J., Tassone, F., & Hertz-Picciotto, I. (2011). Prenatal vitamins, one-carbon metabolism gene variants, and risk for autism. Epidemiology (Cambridge, Mass.), 22(4), 476.
Schmidt, S. V., Nino-Castro, A. C., & Schultze, J. L. (2012). Regulatory dendritic cells: there is more than just immune activation. Frontiers in Immunology, 3, 274.
Sheridan, B. S., & Lefrançois, L. (2010). Intraepithelial lymphocytes: to serve and protect. Current Gastroenterology Reports, 12(6), 513–521.
Shukla, R., Ghoshal, U., Dhole, T. N., & Ghoshal, U. C. (2015). Fecal microbiota in patients with irritable bowel syndrome compared with healthy controls using real-time polymerase chain reaction: an evidence of dysbiosis. Digestive Diseases and Sciences, 60(10), 2953–2962.
Song, Y., Liu, C., & Finegold, S. M. (2004). Real-time PCR quantitation of clostridia in feces of autistic children. Applied and Environmental Microbiology, 70(11), 6459–6465.
Spiller, R. (2008). Serotonin and GI clinical disorders. Neuropharmacology, 55(6), 1072–1080.
Stappenbeck, T. S., & Virgin, H. W. (2016). Accounting for reciprocal host–microbiome interactions in experimental science. Nature, 534(7606), 191–199.
Suzuki, T., Yoshinaga, N., & Tanabe, S. (2011). Interleukin-6 (IL-6) regulates claudin-2 expression and tight junction permeability in intestinal epithelium. Journal of Biological Chemistry, 286(36), 31263–31271.
Suzuki, H., Nishizawa, T., Tani, K., Yamazaki, Y., Tamura, A., Ishitani, R., Dohmae, N., Tsukita, S., Nureki, O., & Fujiyoshi, Y. (2014). Crystal structure of a claudin provides insight into the architecture of tight junctions. Science, 344(6181), 304–307.
Syvänen, A.-C. (2001). Accessing genetic variation: genotyping single nucleotide polymorphisms. Nature Reviews Genetics, 2(12), 930–942.
Tanner, K., Case-Smith, J., Nahikian-Nelms, M., Ratliff-Schaub, K., Spees, C., & Darragh, A. R. (2015). Behavioral and physiological factors associated with selective eating in children with autism spectrum disorder. American Journal of Occupational Therapy, 69(6), 6906180030p6906180031–6906180030p6906180038.
Thulasi, V., Steer, R. A., Monteiro, I. M., & Ming, X. (2018). Overall severities of gastrointestinal symptoms in pediatric outpatients with and without autism spectrum disorder. Autism, 1362361318757564.
Thursby, E., & Juge, N. (2017). Introduction to the human gut microbiota. Biochemical Journal, 474(11), 1823–1836.
Tsilioni, I., & Theoharides, T. C. (2018). Extracellular vesicles are increased in the serum of children with autism spectrum disorder, contain mitochondrial DNA, and stimulate human microglia to secrete IL-1β. Journal of Neuroinflammation, 15(1), 239.
Turner, J. R. (2009). Intestinal mucosal barrier function in health and disease. Nature Reviews Immunology, 9(11), 799–809.
Valicenti-McDermott, M., McVICAR, K., Rapin, I., Wershil, B. K., Cohen, H., & Shinnar, S. (2006). Frequency of gastrointestinal symptoms in children with autistic spectrum disorders and association with family history of autoimmune disease. Journal of Developmental & Behavioral Pediatrics, 27(2), S128–S136.
Van Wijk, F., & Cheroutre, H. (2010). Mucosal T cells in gut homeostasis and inflammation. Expert Review of Clinical Immunology, 6(4), 559–566.
Veldhoen, M., Hirota, K., Westendorf, A. M., Buer, J., Dumoutier, L., Renauld, J.-C., & Stockinger, B. (2008). The aryl hydrocarbon receptor links T H 17-cell-mediated autoimmunity to environmental toxins. Nature, 453(7191), 106.
Verma, D., Chakraborti, B., Karmakar, A., Bandyopadhyay, T., Singh, A. S., Sinha, S., Chatterjee, A., Ghosh, S., Mohanakumar, K., & Mukhopadhyay, K. (2014). Sexual dimorphic effect in the genetic association of monoamine oxidase A (MAOA) markers with autism spectrum disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 50, 11–20.
Visser, J., Rozing, J., Sapone, A., Lammers, K., & Fasano, A. (2009). Tight junctions, intestinal permeability, and autoimmunity. Annals of the New York Academy of Sciences, 1165(1), 195–205.
Vuong, H. E., & Hsiao, E. Y. (2017). Emerging roles for the gut microbiome in autism spectrum disorder. Biological Psychiatry, 81(5), 411–423.
Wan, Y., Hu, Q., Li, T., Jiang, L., Du, Y., Feng, L., Wong, J. C.-M., & Li, C. (2013). Prevalence of autism spectrum disorders among children in China: a systematic review. Shanghai Archives of Psychiatry, 25(2), 70.
Wapenaar, M. C., Monsuur, A., van Bodegraven, A., Weersma, R. K., Bevova, M., Linskens, R., . . . Dijkstra, G. (2007). Associations with tight junction genes PARD3 and MAGI2 in Dutch patients point to a common barrier defect for celiac disease and ulcerative colitis. Gut.
Weiner, H. L., da Cunha, A. P., Quintana, F., & Wu, H. (2011). Oral tolerance. Immunological Reviews, 241(1), 241–259.
Wheeler, M. A., Rothhammer, V., & Quintana, F. J. (2017). Control of immune-mediated pathology via the aryl hydrocarbon receptor. Journal of Biological Chemistry. https://doi.org/10.1074/jbc.R116.767723.
Whitehouse, A. J. (2013). Complementary and alternative medicine for autism spectrum disorders: rationale, safety and efficacy. Journal of Paediatrics and Child Health, 49(9).
Williams, B. L., Hornig, M., Buie, T., Bauman, M. L., Paik, M. C., Wick, I., Bennett, A., Jabado, O., Hirschberg, D. L., & Lipkin, W. I. (2011). Impaired carbohydrate digestion and transport and mucosal dysbiosis in the intestines of children with autism and gastrointestinal disturbances. PLoS One, 6(9), e24585.
Williams, B. L., Hornig, M., Parekh, T., & Lipkin, W. I. (2012). Application of novel PCR-based methods for detection, quantitation, and phylogenetic characterization of Sutterella species in intestinal biopsy samples from children with autism and gastrointestinal disturbances. MBio, 3(1), e00261–e00211.
Wolburg, H., & Lippoldt, A. (2002). Tight junctions of the blood–brain barrier: development, composition and regulation. Vascular Pharmacology, 38(6), 323–337.
Xu, G., Strathearn, L., Liu, B., & Bao, W. (2018). Prevalence of autism spectrum disorder among US children and adolescents, 2014-2016. Jama, 319(1), 81–82.
Zablotsky, B., Black, L. I., Maenner, M. J., Schieve, L. A., & Blumberg, S. J. (2015). Estimated prevalence of autism and other developmental disabilities following questionnaire changes in the 2014. National Health Interview Survey.
Zenewicz, L. A., Yin, X., Wang, G., Elinav, E., Hao, L., Zhao, L., & Flavell, R. A. (2013). IL-22 deficiency alters colonic microbiota to be transmissible and colitogenic. The Journal of Immunology, 190(10), 5306–5312.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Shindler, A.E., Hill-Yardin, E.L., Petrovski, S. et al. Potential Determinants of Gastrointestinal Dysfunction in Autism Spectrum Disorders. Rev J Autism Dev Disord 7, 182–196 (2020). https://doi.org/10.1007/s40489-019-00187-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40489-019-00187-6